Biochemistry, Genetics and Molecular Biology
Blood Clot Lysis
100%
BRCA2
100%
Intron
64%
Allele
55%
Mammalian Target of Rapamycin
50%
CRISPR Activation
50%
Mental Retardation
50%
Population
50%
DNA Repair
50%
Prospective Cohort Study
50%
Polypyrimidine Tract
50%
Homologous Recombination
50%
Morbidity
50%
BRCA1
50%
Pedigree
50%
STK11
50%
Cohort Study
50%
Mouse
50%
Genetic Screening
50%
mTOR Signaling
50%
Hailey-Hailey
50%
Bone Morphogenetic Protein 5
50%
Double-Strand DNA Break
50%
Messenger RNA
49%
Genetics
42%
Germline
42%
Germ Cell
42%
RNA Sequencing
40%
Genetic Divergence
25%
RAD51C
25%
Fibroblast
25%
Myelin Protein Zero
25%
Spastin
25%
Next Generation Sequencing
22%
Nonsense-Mediated Decay
20%
Stem Cell
16%
Heterozygote
16%
Genetic Carrier
16%
Mouse Model
16%
Signal Transduction
16%
Haploinsufficiency
16%
Animal Model
16%
N6-Methyladenosine
16%
Development
16%
mRNA Stability
16%
Cell Count
16%
Induced Pluripotent Stem Cell
16%
Cognition
16%
Brain Development
16%
Autosomal Recessive Disorder
16%
Medicine and Dentistry
Genetic Screening
66%
Intron
64%
Prospective Cohort Study
58%
Apoplexy
50%
Preventive Mastectomy
50%
Genetic Counseling
50%
Contralateral
50%
Breast Cancer
50%
Multiple Sclerosis
50%
Retroviridae
50%
RNA Sequencing
50%
Bone Morphogenetic Protein 5
50%
Hailey-Hailey Disease
50%
Disease
37%
Peutz Jeghers Syndrome
37%
Hazard Ratio
33%
Diagnosis
27%
Medicine
25%
Secondary Prevention
25%
Heritability
25%
Primary Prevention
25%
Nonsense Mediated mRNA Decay
25%
Disease Predisposition
25%
Risk Stratification
16%
Decision Making
16%
Onset Age
16%
Genetic Risk
16%
Exon
14%
Central Nervous System Disease
12%
Cancer Susceptibility
12%
Epstein Barr Virus
12%
Polyposis
12%
Genetic Epidemiology
12%
Ex Vivo
12%
Lymphocyte
12%
Pigmentation
12%
Cycloheximide
12%
Familial Cancer
12%
Next Generation Sequencing
12%
Malignant Neoplasm
12%
Autosomal Dominant Disorder
12%
Base
12%
Outpatient
11%
Bone Disease
10%
Proportional Hazards Model
8%
Quadrantectomy
8%
Cumulative Incidence
8%
Cancer Risk Assessment
8%
Pedigree
8%
Family History
8%
Immunology and Microbiology
Multiple Sclerosis
100%
Retrovirus
64%
DNA Repair
50%
Homologous Recombination
50%
Endogenous Retrovirus
50%
Double-Strand DNA Break
50%
Gene Mutation
25%
Somatic Mutation
25%
Wild Type
25%
Whole Exome Sequencing
25%
Heterozygosity
25%
Allele
25%
Germline Mutation
12%
Tumor Gene
12%
Central Nervous System
12%
Tumor Suppressor Gene
12%
Primary Progressive Multiple Sclerosis
7%
Blood Plasma
7%
Innate Immune System
7%
Single Nucleotide Polymorphism
7%
Autoimmune Disease
7%
X Chromosome
7%
Genetic Variation
7%
Human Immunodeficiency Virus
7%
